MYC and neoplasm: Another example is the study on a mouse model of KRasG12D-driven lung adenoma that evidenced CCL9-mediated recruitment of macrophages and PD-L1-dependent discrimination of T and B cells, where co-blockade of both CCL9 and IL-23 abolished Myc-induced tumor progression, that confirmed tumorigenic properties of CCL9 [31].